Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2009 3
2010 1
2011 3
2012 17
2013 33
2014 34
2015 40
2016 27
2017 37
2018 27
2019 21
2020 30
2021 23
2022 18
2023 32
2024 16
2025 6
2026 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

325 results

Results by year

Filters applied: . Clear all
Page 1
Erdafitinib versus pembrolizumab in pretreated patients with advanced or metastatic urothelial cancer with select FGFR alterations: cohort 2 of the randomized phase III THOR trial.
Siefker-Radtke AO, Matsubara N, Park SH, Huddart RA, Burgess EF, Özgüroğlu M, Valderrama BP, Laguerre B, Basso U, Triantos S, Akapame S, Kean Y, Deprince K, Mukhopadhyay S, Loriot Y; THOR cohort 2 investigators. Siefker-Radtke AO, et al. Ann Oncol. 2024 Jan;35(1):107-117. doi: 10.1016/j.annonc.2023.10.003. Epub 2023 Oct 21. Ann Oncol. 2024. PMID: 37871702 Free article. Clinical Trial.
Non-Coding RNAs and SARS-Related Coronaviruses.
Henzinger H, Barth DA, Klec C, Pichler M. Henzinger H, et al. Among authors: pichler m. Viruses. 2020 Dec 1;12(12):1374. doi: 10.3390/v12121374. Viruses. 2020. PMID: 33271762 Free PMC article. Review.
MicroRNAs as regulators of tumor metabolism.
Ruggieri F, Jonas K, Ferracin M, Dengler M, Jӓger V, Pichler M. Ruggieri F, et al. Among authors: pichler m. Endocr Relat Cancer. 2023 Jul 18;30(8):e220267. doi: 10.1530/ERC-22-0267. Print 2023 Aug 1. Endocr Relat Cancer. 2023. PMID: 37224081 Free article. Review.
Interleukin-6 initiates muscle- and adipose tissue wasting in a novel C57BL/6 model of cancer-associated cachexia.
Pototschnig I, Feiler U, Diwoky C, Vesely PW, Rauchenwald T, Paar M, Bakiri L, Pajed L, Hofer P, Kashofer K, Sukhbaatar N, Schoiswohl G, Weichhart T, Hoefler G, Bock C, Pichler M, Wagner EF, Zechner R, Schweiger M. Pototschnig I, et al. Among authors: pichler m. J Cachexia Sarcopenia Muscle. 2023 Feb;14(1):93-107. doi: 10.1002/jcsm.13109. Epub 2022 Nov 9. J Cachexia Sarcopenia Muscle. 2023. PMID: 36351437 Free PMC article.
Belzutifan plus lenvatinib versus cabozantinib in patients with previously treated advanced renal cell carcinoma (LITESPARK-011): an open-label, randomised, controlled, phase 3 trial.
Motzer RJ, McDermott R, Park SH, Burotto M, Iacovelli R, Verzoni E, Suárez C, Eto M, Cutuli HJ, Porta C, Kopp RM, Rottey S, Velasco G, Valderrama BP, Azad AA, Giorgi U, Pavic M, Tomczak P, Figlin R, Westgeest HM, Guida A, Necchi A, Schutz FA, Suelmann BBM, Haanen JBAG, Yuan SS, Perini RF, Wang D, Heng DYC, Schmidinger M; LITESPARK-011 Investigators. Motzer RJ, et al. Lancet. 2026 Aug 29;408(10557):808-820. doi: 10.1016/S0140-6736(26)01089-5. Epub 2026 Aug 12. Lancet. 2026. PMID: 42586114 Clinical Trial.
Enfortumab vedotin plus pembrolizumab in treatment-naïve metastatic urothelial carcinoma patients: An Austrian real-world analysis.
Niedersuess-Beke D, Mayrhofer K, Krauter J, Franke J, Vais D, Pallauf M, Kiesl D, Luger F, Pfuner J, Terbuch A, Bauernhofer T, Spielgelberg J, Banner A, Aufderklamm S, Wiesinger C, Schnabel S, Gampenrieder SP, Mühlmann J, Vallet S, Weibrecht S, Stoiber F, Andalibi H, Fajkovic H, Taghizadeh H, Miechowiecki J, Taedcke R, Heintel D, Shariat SF, Pichler M, Hilbe W, Pichler R. Niedersuess-Beke D, et al. Among authors: pichler m. Int J Cancer. 2026 Mar 15;158(6):1654-1665. doi: 10.1002/ijc.70203. Epub 2025 Oct 22. Int J Cancer. 2026. PMID: 41123038 Free PMC article.
Tumor macroenvironment and metabolism.
Al-Zoughbi W, Al-Zhoughbi W, Huang J, Paramasivan GS, Till H, Pichler M, Guertl-Lackner B, Hoefler G. Al-Zoughbi W, et al. Among authors: pichler m. Semin Oncol. 2014 Apr;41(2):281-95. doi: 10.1053/j.seminoncol.2014.02.005. Epub 2014 Mar 1. Semin Oncol. 2014. PMID: 24787299 Free PMC article. Review.
MicroRNAs, genomic instability and cancer.
Vincent K, Pichler M, Lee GW, Ling H. Vincent K, et al. Among authors: pichler m. Int J Mol Sci. 2014 Aug 20;15(8):14475-91. doi: 10.3390/ijms150814475. Int J Mol Sci. 2014. PMID: 25141103 Free PMC article. Review.
FGFR1/3 Signaling as an Achilles' Heel of Phenotypic Diversity in Urothelial Carcinoma.
Pichler R, van Creij NCH, Mertens LS, Del Giudice F, Koll F, Soria F, Subiela JD, Plage H, Tymoszuk P, Mayr R, Klinglmair G, Seeber A, Pichler M, Günther M, Ormanns S, Compérat E, Li R, Moschini M, Pradére B; European Association of Urology-Young Academic Urologists Urothelial Carcinoma Working Group. Pichler R, et al. Among authors: pichler m. Eur Urol Oncol. 2026 Apr;9(2):220-226. doi: 10.1016/j.euo.2025.07.005. Epub 2025 Jul 28. Eur Urol Oncol. 2026. PMID: 40716983 Free article.
325 results